Suppr超能文献

树突状细胞溶酶体蛋白对新型隐球菌的抗真菌活性。

Antifungal activity of dendritic cell lysosomal proteins against Cryptococcus neoformans.

机构信息

Department of Microbiology and Molecular Genetics, Oklahoma State University, 307 Life Science East, Stillwater, OK, 74078, USA.

Department of Biology, South Texas Center for Emerging Infectious Diseases, San Antonio, TX, USA.

出版信息

Sci Rep. 2021 Jun 30;11(1):13619. doi: 10.1038/s41598-021-92991-6.

Abstract

Cryptococcal meningitis is a life-threatening disease among immune compromised individuals that is caused by the opportunistic fungal pathogen Cryptococcus neoformans. Previous studies have shown that the fungus is phagocytosed by dendritic cells (DCs) and trafficked to the lysosome where it is killed by both oxidative and non-oxidative mechanisms. While certain molecules from the lysosome are known to kill or inhibit the growth of C. neoformans, the lysosome is an organelle containing many different proteins and enzymes that are designed to degrade phagocytosed material. We hypothesized that multiple lysosomal components, including cysteine proteases and antimicrobial peptides, could inhibit the growth of C. neoformans. Our study identified the contents of the DC lysosome and examined the anti-cryptococcal properties of different proteins found within the lysosome. Results showed several DC lysosomal proteins affected the growth of C. neoformans in vitro. The proteins that killed or inhibited the fungus did so in a dose-dependent manner. Furthermore, the concentration of protein needed for cryptococcal inhibition was found to be non-cytotoxic to mammalian cells. These data show that many DC lysosomal proteins have antifungal activity and have potential as immune-based therapeutics.

摘要

隐球菌性脑膜炎是一种威胁生命的疾病,发生于免疫功能低下的个体,由机会性真菌病原体新生隐球菌引起。既往研究表明,真菌被树突状细胞(DC)吞噬,并转运至溶酶体,在那里通过氧化和非氧化机制被杀死。尽管已知溶酶体中的某些分子可以杀死或抑制新生隐球菌的生长,但溶酶体是一种包含许多不同蛋白质和酶的细胞器,旨在降解吞噬的物质。我们假设多种溶酶体成分,包括半胱氨酸蛋白酶和抗菌肽,可能抑制新生隐球菌的生长。我们的研究鉴定了 DC 溶酶体的内容物,并检查了溶酶体中发现的不同蛋白质的抗隐球菌特性。结果表明,几种 DC 溶酶体蛋白影响体外新生隐球菌的生长。杀死或抑制真菌的蛋白质以剂量依赖的方式起作用。此外,发现抑制隐球菌所需的蛋白质浓度对哺乳动物细胞没有细胞毒性。这些数据表明,许多 DC 溶酶体蛋白具有抗真菌活性,并具有作为免疫为基础的治疗剂的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/8245489/31a282f547ef/41598_2021_92991_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验